The Department does not collect information on which providers have been awarded contracts at local level.<\/p>
<\/p>
<\/p>
<\/p>
It is for local commissioners to decide how best to secure local services and take a decision on which are the most capable providers to deliver those services in the best interests of their patients. There is no requirement for commissioners to put all services out to competitive tender.<\/p>
<\/p>
<\/p>
<\/p>
Whether NHS services are provided by the public, voluntary or private sector, they remain publicly funded and free at the point of delivery with access based on clinical need.<\/p>
<\/p>
<\/strong><\/p> <\/p>"}
, "answeringMember" : {"_about" : "http://data.parliament.uk/members/3918", "label" : {"_value" : "Biography information for Jane Ellison"}
}
, "answeringMemberConstituency" : {"_value" : "Battersea"}
, "answeringMemberPrinted" : {"_value" : "Jane Ellison"}
, "dateOfAnswer" : {"_value" : "2014-11-27", "_datatype" : "dateTime"}
, "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"}
, "questionFirstAnswered" : [{"_value" : "2014-11-27T17:29:33.887Z", "_datatype" : "dateTime"}
]}
, "answeringDeptId" : {"_value" : "17"}
, "answeringDeptShortName" : {"_value" : "Health"}
, "answeringDeptSortName" : {"_value" : "Health"}
, "date" : {"_value" : "2014-11-24", "_datatype" : "dateTime"}
, "hansardHeading" : {"_value" : "NHS: Procurement"}
, "houseId" : {"_value" : "1"}
, "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"}
}
], "questionText" : "To ask the Secretary of State for Health, how many contracts of what value were signed by NHS commissioners with non-NHS providers in 2009-10.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
, "tablingMember" : {"_about" : "http://data.parliament.uk/members/4016", "label" : {"_value" : "Biography information for Sir George Hollingbery"}
}
, "tablingMemberConstituency" : {"_value" : "Meon Valley"}
, "tablingMemberPrinted" : [{"_value" : "George Hollingbery"}
], "uin" : "215711"}
, {"_about" : "http://data.parliament.uk/resources/164365", "AnsweringBody" : [{"_value" : "Department of Health"}
], "answer" : {"_about" : "http://data.parliament.uk/resources/164365/answer", "answerText" : {"_value" : " The Government is committed to reforming progression pay in the National Health Service to ensure that the system is fair, consistent and sustainable.<\/p> <\/p> <\/p> <\/p> Over 50% (around 620,000 headcount) of hospital and community health services staff are eligible for incremental pay increases; subject to meeting local performance standards.<\/p> <\/p> <\/p> <\/p> All of these eligible staff will receive at least a 1% increase.<\/p> <\/p> <\/p> <\/p> Two thirds of those staff are eligible for at least 3%, which is the average incremental increase. This is around 410,000 staff (headcount).<\/p> <\/p>"}
, "answeringMember" : {"_about" : "http://data.parliament.uk/members/3932", "label" : {"_value" : "Biography information for Dr Dan Poulter"}
}
, "answeringMemberConstituency" : {"_value" : "Central Suffolk and North Ipswich"}
, "answeringMemberPrinted" : {"_value" : "Dr Daniel Poulter"}
, "dateOfAnswer" : {"_value" : "2014-11-27", "_datatype" : "dateTime"}
, "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"}
, "questionFirstAnswered" : [{"_value" : "2014-11-27T16:42:27.31Z", "_datatype" : "dateTime"}
]}
, "answeringDeptId" : {"_value" : "17"}
, "answeringDeptShortName" : {"_value" : "Health"}
, "answeringDeptSortName" : {"_value" : "Health"}
, "date" : {"_value" : "2014-11-24", "_datatype" : "dateTime"}
, "hansardHeading" : {"_value" : "NHS: Pay"}
, "houseId" : {"_value" : "1"}
, "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"}
}
], "questionText" : "To ask the Secretary of State for Health, what proportion of NHS staff are eligible for incremental pay awards; and how many of those will receive at least (a) one per cent and (b) three per cent pay increases this year.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
, "tablingMember" : {"_about" : "http://data.parliament.uk/members/268", "label" : {"_value" : "Biography information for Sir Peter Luff"}
}
, "tablingMemberConstituency" : {"_value" : "Mid Worcestershire"}
, "tablingMemberPrinted" : [{"_value" : "Sir Peter Luff"}
], "uin" : "215716"}
, {"_about" : "http://data.parliament.uk/resources/164367", "AnsweringBody" : [{"_value" : "Department of Health"}
], "answer" : {"_about" : "http://data.parliament.uk/resources/164367/answer", "answerText" : {"_value" : " Oral medications are widely used to control high blood glucose levels in patients with type 2 diabetes, leading to reductions in long-term complications of diabetes such as heart and kidney disease. The risk of hypoglycaemia associated with these drugs is well-known and is evaluated in detail both at the time of marketing authorisation approval and in the post-marketing period.<\/p> <\/p> <\/p> <\/p> The Patient Information Leaflet provided with all oral diabetes treatments contains advice on the risk of hypoglycaemia while driving. Patients are instructed to take appropriate precautions or to avoid driving completely if affected by hypoglycaemia.<\/p> <\/p> <\/p> <\/p> In addition, the Driver and Vehicle Licensing Agency\u2019s \u2018At a glance guide to the current medical standards of fitness to drive\u2019 (May 2014) provides detailed advice to healthcare professionals on the management of patients receiving oral diabetes therapies who wish to drive.<\/p> <\/p> <\/p> <\/p> The Medicines and Healthcare products Regulatory Agency keeps the safety of medicines under continual review and is in regular discussion on relevant issues with the DVLA and the Department for Transport, most recently regarding the development of public communications for the new offence of driving with certain drugs taken above specified limits, which is due to come into force in March 2015. The new offence mainly involves illegal drugs and those with sedative effects and does not include treatments for diabetes.<\/p> <\/p> <\/strong><\/p> <\/p>"}
, "answeringMember" : {"_about" : "http://data.parliament.uk/members/4020", "label" : {"_value" : "Biography information for George Freeman"}
}
, "answeringMemberConstituency" : {"_value" : "Mid Norfolk"}
, "answeringMemberPrinted" : {"_value" : "George Freeman"}
, "dateOfAnswer" : {"_value" : "2014-11-27", "_datatype" : "dateTime"}
, "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"}
, "questionFirstAnswered" : [{"_value" : "2014-11-27T16:53:36.827Z", "_datatype" : "dateTime"}
]}
, "answeringDeptId" : {"_value" : "17"}
, "answeringDeptShortName" : {"_value" : "Health"}
, "answeringDeptSortName" : {"_value" : "Health"}
, "date" : {"_value" : "2014-11-24", "_datatype" : "dateTime"}
, "hansardHeading" : {"_value" : "Driving: Diabetes"}
, "houseId" : {"_value" : "1"}
, "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"}
}
], "questionText" : "To ask the Secretary of State for Health, what discussions his Department has had with the Driver and Vehicle Licensing Agency about the prescription of oral medications for type 2 diabetes that carry an increased risk of hypoglycaemia.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
, "tablingMember" : {"_about" : "http://data.parliament.uk/members/1538", "label" : {"_value" : "Biography information for Rosie Cooper"}
}
, "tablingMemberConstituency" : {"_value" : "West Lancashire"}
, "tablingMemberPrinted" : [{"_value" : "Rosie Cooper"}
], "uin" : "215647"}
, {"_about" : "http://data.parliament.uk/resources/164369", "AnsweringBody" : [{"_value" : "Department of Health"}
], "answer" : {"_about" : "http://data.parliament.uk/resources/164369/answer", "answerText" : {"_value" : " The Care Quality Commission (CQC) is the independent regulator of health and adult social care in England. The CQC has provided the following information.<\/p> <\/p> <\/p> <\/p> The CQC published its first round of Intelligent Monitoring for general practices on 17 November 2014. Intelligent Monitoring analyses a range of indicators (including surveys and official statistics) to create priority bands for inspection. The bandings are then used to help inform where the CQC prioritise its inspections. The CQC will also use the indicators to raise questions about the quality of care; they will not be used on their own to make final judgements about the quality of care.<\/p> <\/p> <\/p> <\/p> The CQC informed all providers of the launch of general practitioner Intelligent Monitoring with an email that was sent out on 14 November 2014 (with no data included). All band 1 GP practices received a separate email on 14 November 2014 informing them that they were in the highest priority band for inspection.<\/p> <\/p> <\/p> <\/p> The CQC engaged with approximately 400 GP practices prior to the launch of GP Intelligent Monitoring, including sharing the data and hosting a series of meetings. A national media release was sent out on the morning of 17 November.<\/p> <\/p> <\/p> <\/p> The CQC will listen and respond to concerns raised by GP practices. The CQC\u2019s formal appeals processes are for the regulatory judgements the CQC makes and Intelligent Monitoring, is not a regulatory judgement. This comparative information is already in the public domain and known to the practice. The CQC publish this information to be open and transparent about what it knows about providers.<\/p> <\/p> <\/p> <\/p> The CQC plans to update this information every three months so that it can continue to respond to issues as they emerge and to share these with providers and the public. The CQC will be undertaking additional testing and engagement to continually improve indicators to inform this work, and will align its definitions of indicators as far as possible with those used by partner bodies such as NHS England and Public Health England.<\/p> <\/p> <\/p> <\/p> Within the next two years, the CQC will have inspected and rated every general practice in England as Outstanding, Good, Requires Improvement, or Inadequate to help people make informed choices about their care and encourage improvement in quality.<\/p> <\/p>"}
, "answeringMember" : {"_about" : "http://data.parliament.uk/members/1439", "label" : {"_value" : "Biography information for Norman Lamb"}
}
, "answeringMemberConstituency" : {"_value" : "North Norfolk"}
, "answeringMemberPrinted" : {"_value" : "Norman Lamb"}
, "dateOfAnswer" : {"_value" : "2014-11-27", "_datatype" : "dateTime"}
, "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"}
, "questionFirstAnswered" : [{"_value" : "2014-11-27T17:04:42.597Z", "_datatype" : "dateTime"}
]}
, "answeringDeptId" : {"_value" : "17"}
, "answeringDeptShortName" : {"_value" : "Health"}
, "answeringDeptSortName" : {"_value" : "Health"}
, "date" : {"_value" : "2014-11-24", "_datatype" : "dateTime"}
, "hansardHeading" : {"_value" : "Primary Health Care"}
, "houseId" : {"_value" : "1"}
, "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"}
}
], "questionText" : "To ask the Secretary of State for Health, with reference to the Care Quality Commission's risk register relating to primary care, when primary care practices were informed of their ratings; when national and local media were informed of the ratings relating to specific practices nationally or in their locality; and what rights primary care practices have to appeal against the theoretical assessments undertaken nationally without those specific practices having been inspected or given the opportunity to review the data on which the risk assessment was made.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
, "tablingMember" : {"_about" : "http://data.parliament.uk/members/395", "label" : {"_value" : "Biography information for Lord Blunkett"}
}
, "tablingMemberConstituency" : {"_value" : "Sheffield, Brightside and Hillsborough"}
, "tablingMemberPrinted" : [{"_value" : "Mr David Blunkett"}
], "uin" : "215717"}
, {"_about" : "http://data.parliament.uk/resources/164370", "AnsweringBody" : [{"_value" : "Department of Health"}
], "answer" : {"_about" : "http://data.parliament.uk/resources/164370/answer", "answerText" : {"_value" : " Patient experience surveys are a valuable source of evidence and the results are used in a range of ways, including the assessment of National Health Service performance as well as in regulatory activities such as registration, monitoring ongoing compliance and reviews. The Care Quality Commission has developed a new Intelligent Monitoring tool to give inspectors a clear picture of the areas of care that need to be followed up within an NHS acute trust or a specialist NHS trust. The system is built on a set of indicators that look at a range of information including patient experience, staff experience and performance.<\/p> <\/p> <\/p> <\/p> In addition to the patient experience surveys hospital boards and other providers and commissioners of services can also consider the results of the Friends and Family Test (FFT) to consider the implications for quality and safety. While not a traditional survey, the FFT provides near real-time feedback to identify both good and poor quality patient experience. A NHS England review of the FFT found that it is performing well as a service improvement tool, with 85% of trusts reporting that it is being used to improve patient experience, and 78% saying that FFT has increased the emphasis placed on patient experience in their trusts.<\/p> <\/p> <\/p> <\/p>"}
, "answeringMember" : {"_about" : "http://data.parliament.uk/members/4020", "label" : {"_value" : "Biography information for George Freeman"}
}
, "answeringMemberConstituency" : {"_value" : "Mid Norfolk"}
, "answeringMemberPrinted" : {"_value" : "George Freeman"}
, "dateOfAnswer" : {"_value" : "2014-11-27", "_datatype" : "dateTime"}
, "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"}
, "questionFirstAnswered" : [{"_value" : "2014-11-27T17:09:16.957Z", "_datatype" : "dateTime"}
]}
, "answeringDeptId" : {"_value" : "17"}
, "answeringDeptShortName" : {"_value" : "Health"}
, "answeringDeptSortName" : {"_value" : "Health"}
, "date" : {"_value" : "2014-11-24", "_datatype" : "dateTime"}
, "hansardHeading" : {"_value" : "Patients: Safety"}
, "houseId" : {"_value" : "1"}
, "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"}
}
], "questionText" : "To ask the Secretary of State for Health, what plans he has to increase the use of patient experience surveys in the NHS to inform patient safety initiatives; and if he will make a statement.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
, "tablingMember" : {"_about" : "http://data.parliament.uk/members/1503", "label" : {"_value" : "Biography information for Mr Jamie Reed"}
}
, "tablingMemberConstituency" : {"_value" : "Copeland"}
, "tablingMemberPrinted" : [{"_value" : "Mr Jamie Reed"}
], "uin" : "215718"}
, {"_about" : "http://data.parliament.uk/resources/164371", "AnsweringBody" : [{"_value" : "Department of Health"}
], "answer" : {"_about" : "http://data.parliament.uk/resources/164371/answer", "answerText" : {"_value" : "